References
European Commission. Memo 10/325: Questions and Answers on the EU's New Approach to the Cultivation of GMOs (European Commission, Brussels, 2010).
Ramessar, K. et al. Nat. Biotechnol. 28, 133–136 (2010).
European Commission. EU Trade in Agricultural Products 2009 (European Commission, Brussels, 2009).
Peng, W. Nat. Biotechnol. 29, 302 (2011).
US Department of Agriculture. GAIN Report: EU-27 Biotechnology. GE Plants and Animals (USDA, Washington, DC, 2009).
Brookes, G. & Barfoot, P. GM Crops: Global Socio-economic and Environmental Impacts 1996–2008. (PG Economics Ltd., 2010).
Acknowledgements
Research in our laboratory is supported by the Spanish Ministry of Science and Innovation (MICINN), Spain (BFU2007-61413); European Union Framework 6 Program—The Pharma-Planta Integrated Project LSH-2002-1.2.5-2; European Union Framework 7 Program-SmartCell Integrated Project 222716; European Union Framework 7 European Research Council IDEAS Advanced Grant (to P.C.) Program-BIOFORCE; COST Action FA0804: Molecular farming: plants as a production platform for high value proteins; and Centre CONSOLIDER on Agrigenomics, funded by MICINN, Spain.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Sabalza, M., Miralpeix, B., Twyman, R. et al. EU legitimizes GM crop exclusion zones. Nat Biotechnol 29, 315–317 (2011). https://doi.org/10.1038/nbt.1840
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt.1840
- Springer Nature America, Inc.
This article is cited by
-
Fruit crops in the era of genome editing: closing the regulatory gap
Plant Cell Reports (2021)
-
Removing politics from innovations that improve food security
Transgenic Research (2021)
-
Status and market potential of transgenic biofortified crops
Nature Biotechnology (2015)
-
Towards a more open debate about values in decision-making on agricultural biotechnology
Transgenic Research (2014)
-
Recombinant plant-derived pharmaceutical proteins: current technical and economic bottlenecks
Biotechnology Letters (2014)